文献速递胃肠外科围术期管理与 ERAS

加速康复方案下微创手术对直肠肿瘤切除短期结局的影响

Impact of minimally invasive surgery on short-term outcomes after rectal resection for neoplasm within the setting of an enhanced recovery program.
PubMed 文献 · Surg Endosc · 2017-11-03

单中心回顾性分析2010至2015年325例择期直肠肿瘤切除患者,比较开放与微创手术在加速康复方案实施前后的结局。微创手术比例在加速康复实施后显著上升,微创联合加速康复方案与更短住院时间相关,30天并发症率数值上更低。

要点

  • 加速康复方案实施后微创手术比例从6.1%升至23.1%和54.4%。
  • 加速康复联合微创手术患者中位住院时间3天,30天并发症率14.5%。
  • 微创联合加速康复方案与住院时间缩短显著相关。

核心结论

  • 微创手术联合加速康复方案与直肠肿瘤切除患者住院时间缩短显著相关。

研究设计与样本

  • 单中心回顾性分析,纳入2010至2015年325例择期开放或微创直肠肿瘤切除患者。
  • 微创手术定义为任何腹腔镜或机器人手术,加速康复方案于2013年8月实施。

主要发现

  • 325例中252例(77.5%)接受开放手术,73例(22.5%)接受微创手术。
  • 加速康复实施前微创比例为6.1%,实施后2年内分别为23.1%和54.4%(p < 0.001)。
  • 加速康复实施前中位住院时间7天(n = 181),30天并发症率23.8%。
  • 加速康复实施后中位住院时间4天(n = 144);开放手术患者中位住院时间5.5天(n = 82),30天并发症率19.5%。
  • 加速康复联合微创手术患者中位住院时间3天(n = 62),30天并发症率14.5%。

关键数值与推荐

  • 单因素回归显示加速康复方案下微创手术患者较非加速康复方案下开放手术患者更可能实现住院时间缩短(< 6天)(均p < 0.001)。

临床怎么用

  • 在加速康复方案框架下优先考虑微创手术可能有助于缩短直肠肿瘤切除患者住院时间。

局限性

  • 单中心回顾性设计,样本量有限,需进一步研究确定从肿瘤学角度最适合微创手术的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive surgery (MIS) for rectal cancer has increased in recent years. Enhanced recovery (ER) protocols are associated with improved outcomes, such as decreased length of stay (LOS). We examined the impact of MIS and ER protocols on outcomes after rectal resection for neoplasm. METHODS: A retrospective analysis was performed for patients undergoing elective open (OS) or MIS rectal resection for neoplasm from 2010 to 2015 at a single institution. MIS was defined as any laparoscopic or robotic procedure. An ER protocol was implemented in 8/2013. Regression models were used to estimate outcomes including LOS, 30-day morbidity, readmission, and hospital costs. RESULTS: Among 325 patients, 252 (77.5%) underwent OS; 73 (22.5%) underwent MIS rectal resection. Prior to ER implementation, only 6.1% underwent MIS, compared to 23.1 and 54.4% in the 2 years following ER implementation (p < 0.001). Prior to ER implementation, median LOS was 7 days (n = 181) with 23.8% 30-day morbidity. Following ER implementation, median LOS was 4 days (n = 144); patients receiving OS had median LOS of 5.5 days (n = 82) and 30-day morbidity of 19.5%. ER patients receiving MIS had median LOS of 3 days (n = 62) and 30-day morbidity of 14.5%. Univariate regression demonstrated that MIS patients on ER protocol were more likely to have a shortened LOS (< 6 days) compared to OS patients on non-ER protocol (both p < 0.001). CONCLUSIONS: The combination of MIS and ER protocol is significantly associated with reduced LOS for patients undergoing rectal resection for neoplasm. Further research is needed to determine which patients are best suited to MIS from an oncologic standpoint.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Martin AN, Berry PS, Friel CM, et al. Impact of minimally invasive surgery on short-term outcomes after rectal resection for neoplasm within the setting of an enhanced recovery program. Surg Endosc. 2017. PMID: 29101566. doi:10.1007/s00464-017-5956-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。